Homologous recombinational repair vis-à-vis chlorambucil resistance in chronic lymphocytic leukemia

This publication has 12 references indexed in Scilit:

• In Vitro Evidence for Homologous Recombinational Repair in Resistance to Melphalan
  JNCI Journal of the National Cancer Institute, 2001
• Homologous recombinational repair of DNA ensures mammalian chromosome stability
  Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, 2001
• DNA repair and recombination factor Rad51 is over-expressed in human pancreatic adenocarcinoma
  Oncogene, 2000
• Increased expression of human DNA repair genes, XRCC1, XRCC3 and RAD51, in radioresistant human KB carcinoma cell line N10
  Oral Oncology, 1998
• Initiation of DNA Interstrand Cross-Link Repair in Humans: the Nucleotide Excision Repair System Makes Dual Incisions 5′ to the Cross-linked Base and Removes a 22- to 28-Nucleotide-long Damage-Free Strand
  Molecular and Cellular Biology, 1997
• DNA Repair: Enzymatic Mechanisms and Relevance to Drug Response
  JNCI Journal of the National Cancer Institute, 1996
• Why Do Drugs Work in CLL?
  Leukemia & Lymphoma, 1996
• Effect of alkyl-N-purine DNA glycosylase overexpression on cellular resistance to bifunctional alkylating agents
  Biochemical Pharmacology, 1995
• Nitrogen mustard drug resistant B-cell chronic lymphocytic leukemia as an in vivo model for crosslinking agent resistance
  Mutation Research/DNA Repair, 1995
• Correlation of resistance to nitrogen mustards in chronic lymphocytic leukemia with enhanced removal of melphalan-induced DNA cross-links
  Biochemical Pharmacology, 1989